BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17229041)

  • 1. A cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma.
    Aburuz S; Heaney LG; Millership J; Gamble J; McElnay J
    Br J Clin Pharmacol; 2007 Jan; 63(1):110-5. PubMed ID: 17229041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
    Wilson AM; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between fluticasone furoate systemic exposure and cortisol suppression.
    Allen A
    Clin Pharmacokinet; 2013 Oct; 52(10):885-96. PubMed ID: 23719680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
    Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma.
    Sim D; Griffiths A; Armstrong D; Clarke C; Rodda C; Freezer N
    Eur Respir J; 2003 Apr; 21(4):633-6. PubMed ID: 12762348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of asthma treatment on urinary growth hormone excretion in children.
    O'Leary PC; McIntyre E; Feddema P; LeSouëf PN
    Pediatr Pulmonol; 1996 Jun; 21(6):361-6. PubMed ID: 8927462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
    Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L
    J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair cortisol and inhaled corticosteroid use in asthmatic children.
    Baan EJ; van den Akker ELT; Engelkes M; de Rijke YB; de Jongste JC; Sturkenboom MCJM; Verhamme KM; Janssens HM
    Pediatr Pulmonol; 2020 Feb; 55(2):316-321. PubMed ID: 31651095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate.
    Eid N; Morton R; Olds B; Clark P; Sheikh S; Looney S
    Pediatrics; 2002 Feb; 109(2):217-21. PubMed ID: 11826198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
    Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ; Kaliner MA; LaForce CF; Baker JW; Kaiser HB; Amin D; Kundu S; Williams JE; Engelstaetter R; Banerji DD
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.
    Wilson AM; Sims EJ; Lipworth BJ
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):329-35. PubMed ID: 10435058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
    Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
    J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
    Wilson AM; Lipworth BJ
    Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of nonadherence in difficult asthma.
    Gamble J; Stevenson M; McClean E; Heaney LG
    Am J Respir Crit Care Med; 2009 Nov; 180(9):817-22. PubMed ID: 19644048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
    Clark DJ; Lipworth BJ
    Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone propionate in children with moderate asthma.
    Hoekstra MO; Grol MH; Bouman K; Stijnen T; Köeter GH; Kauffman HF; Gerritsen J
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of fluticasone propionate on linear growth in preschool children with asthma.
    Stefanovic IM; Verona E; Cicak B; Vrsalovic R
    Pediatr Int; 2011 Oct; 53(5):672-676. PubMed ID: 21342354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.